CA2338946A1
(en)
|
|
Hepatitis c inhibitor tri-peptides
|
RU2428428C2
(ru)
|
|
Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
|
RS67004A
(en)
|
|
Macrocyclic peptides active against the hepatitis c virus
|
DE602004023924D1
(en)
|
|
Ease-hemmer
|
AU2003275826A1
(en)
|
|
Macrocyclic peptides active against the hepatitis c virus
|
WO2004113365A3
(en)
|
|
Hepatitis c serine protease tri-peptide inhibitors
|
RS67204A
(en)
|
|
Tripeptides having a hydroxyproline ether of a substituted quinoline for inhibition of ns3 (hepatitis c)
|
WO2004072243A3
(en)
|
|
Macrocyclic hepatitis c serine protease inhibitors
|
YU9301A
(sh)
|
|
Peptidi kao inhibitori hepatitisa c
|
MY137301A
(en)
|
|
Peptide analogs as irreversible interleukin-1b protease inhibitors
|
BRPI0412761A
(pt)
|
|
inibidores de serino proteases, particularmente a protease ns3-ns4a do vhc
|
BRPI0008753B8
(pt)
|
|
composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
|
AU2505297A
(en)
|
|
Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect
|
BRPI0409465A
(pt)
|
|
derivados de carboxamida como agentes antidiabéticos
|
HUT57773A
(en)
|
|
Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
|
YU34396A
(sh)
|
|
Farmaceutske smeše korisne za minimiziranje oštećenja kostiju
|
RU2475498C1
(ru)
|
|
Новые производные гемина с антибактериальной и противовирусной активностью
|
RU2220953C2
(ru)
|
|
Ненасыщенные производные гидроксимовой кислоты в качестве ингибиторов nadnad+ - adp-рибозилтрансферазы
|
TH59047A3
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
|
|
TH57310C3
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
|
|
DK0643061T3
(da)
|
|
Nye cephalosporin-antibitotika
|
KR900009677A
(ko)
|
|
신규 화합물들
|
ID21546A
(id)
|
|
Turunan-turunan amida baru dan komposisi-komposisi obat darinya
|
EA200000374A2
(ru)
|
|
Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
|
KR910011893A
(ko)
|
|
헤테로시클릭 아미노디올 β-아미노산 유도체
|